Sequence information
Variant position: 328 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 821 The length of the canonical sequence.
Location on the sequence:
YLKVLKAAGVNTTDKEIEVL
Y IRNVTFEDAGEYTCLAGNSI
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human YLKVLKAAGVNTTDKEIEVLY IRNVTFEDAGEYTCLAGNSI
Mouse YLKVLKAAGVNTTDKEIEVLY IRNVTFEDAGEYTCLAGNSI
Chicken YLQVLKAAGVNTTDKEIEVLY IRNVTFEDAGEYTCLAGNSI
Xenopus laevis YFKVLKAAGVNVTDEEIEVLY VRNVSFEDAGEYTCIAGNSI
Zebrafish YVRVLKTAGVNTTDKEIEVLY LPNVTFEDAGEYTCLAGNSI
Drosophila SVEI-QNLNFTVTNDSV-VLT LRNVTFDQEGWYTCLASSGL
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
Chain
22 – 821
Fibroblast growth factor receptor 2
Topological domain
22 – 377
Extracellular
Domain
256 – 358
Ig-like C2-type 3
Glycosylation
318 – 318
N-linked (GlcNAc...) asparagine
Glycosylation
331 – 331
N-linked (GlcNAc...) asparagine
Disulfide bond
278 – 342
Alternative sequence
250 – 361
Missing. In isoform 17.
Alternative sequence
255 – 821
Missing. In isoform 8.
Alternative sequence
313 – 313
K -> KVTK. In isoform 10.
Alternative sequence
314 – 429
Missing. In isoform 9.
Alternative sequence
314 – 330
AAGVNTTDKEIEVLYIR -> HSGINSSNAEVLALF. In isoform 3, isoform 4, isoform 11, isoform 12, isoform 13 and isoform 16.
Literature citations
Jackson-Weiss and Crouzon syndromes are allelic with mutations in fibroblast growth factor receptor 2.
Jabs E.W.; Li X.; Scott A.F.; Meyers G.A.; Chen W.; Eccles M.; Mao J.; Charnas L.R.; Jackson C.E.; Jaye M.;
Nat. Genet. 8:275-279(1994)
Cited for: VARIANTS CS CYS-328 AND CYS-347; VARIANT JWS GLY-344;
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.